Characterization and Gene Expression Analysis of Serum-Derived Extracellular Vesicles in Primary Aldosteronism.
暂无分享,去创建一个
G. Camussi | M. Deregibus | M. Tetti | F. Veglio | P. Mulatero | S. Monticone | J. Burrello | Chiara Gai | T. Lopatina
[1] Thomas Kahan,et al. [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.
[2] Cory B. Giles,et al. Endothelial dysfunction and angiogenesis impairment in the ageing vasculature , 2018, Nature Reviews Cardiology.
[3] Thomas Kahan,et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.
[4] W. Young,et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. , 2017, The lancet. Diabetes & endocrinology.
[5] F. Veglio,et al. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. , 2017, Journal of the American College of Cardiology.
[6] N. Câmara,et al. NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage , 2016, Circulation.
[7] M. Brizzi,et al. Charge-based precipitation of extracellular vesicles , 2016, International journal of molecular medicine.
[8] David S. Wishart,et al. Heatmapper: web-enabled heat mapping for all , 2016, Nucleic Acids Res..
[9] Bin Wang,et al. Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury , 2016, Oncotarget.
[10] W. Young,et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.
[11] N. Kashihara,et al. Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] A. Nakashima,et al. Effect of Aldosterone-Producing Adenoma on Endothelial Function and Rho-Associated Kinase Activity in Patients With Primary Aldosteronism , 2015, Hypertension.
[13] L. O’Driscoll,et al. Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.
[14] C. Bode,et al. Role of microparticles in endothelial dysfunction and arterial hypertension. , 2014, World journal of cardiology.
[15] D. Jahn,et al. Aldosterone induces fibrosis, oxidative stress and DNA damage in livers of male rats independent of blood pressure changes. , 2014, Toxicology and applied pharmacology.
[16] B. Cain,et al. Aldosterone alters the chromatin structure of the murine endothelin-1 gene. , 2013, Life sciences.
[17] Lynne T. Bemis,et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.
[18] G. Müller,et al. Microvesicles/exosomes as potential novel biomarkers of metabolic diseases , 2012, Diabetes, metabolic syndrome and obesity : targets and therapy.
[19] Paul J. Harrison,et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[20] R. Touyz,et al. Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid Rafts , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[21] C. Piantadosi,et al. Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression* , 2011, The Journal of Biological Chemistry.
[22] L. Ghiadoni,et al. Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism , 2008, Journal of hypertension.
[23] U. de Faire,et al. Retrospective Analysis of Coagulation Factor II Receptor (F2R) Sequence Variation and Coronary Heart Disease in Hypertensive Patients , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[24] Y. Castier,et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. , 2007, Journal of the American College of Cardiology.
[25] J Ratajczak,et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery , 2006, Leukemia.
[26] Chantal M Boulanger,et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.
[27] J. Al Suwaidi,et al. Endothelial Dysfunction: Cardiovascular Risk Factors, Therapy, and Outcome , 2005, Vascular health and risk management.
[28] A. Zeiher,et al. Endothelial Function: Cardiac Events , 2005, Circulation.
[29] P. Ganz,et al. Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.
[30] D. Calhoun,et al. Impaired Endothelium-Dependent Flow-Mediated Vasodilation in Hypertensive Subjects With Hyperaldosteronism , 2004, Circulation.
[31] E. Schiffrin,et al. Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats , 2004, Hypertension.
[32] W. Jy,et al. Elevated plasma endothelial microparticles in preeclampsia. , 2003, American journal of obstetrics and gynecology.
[33] E. Schiffrin,et al. Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling , 2003, Hypertension.
[34] M. Peakman,et al. Persistent Infection of Human Microvascular Endothelial Cells by Coxsackie B Viruses Induces Increased Expression of Adhesion Molecules 1 , 2003, The Journal of Immunology.
[35] L. Horstman,et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. , 2003, American heart journal.
[36] Richard A. Preston,et al. Effects of Severe Hypertension on Endothelial and Platelet Microparticles , 2003, Hypertension.
[37] A. Struthers,et al. Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. , 2002, Clinical science.
[38] Patrice Darmon,et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. , 2002, Diabetes.
[39] F. Martinon,et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.
[40] Ricardo Rocha,et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. , 2002, American journal of physiology. Heart and circulatory physiology.
[41] C. Tortorella,et al. Endothelin-1 stimulates aldosterone synthesis in Conn's adenomas via both A and B receptors coupled with the protein kinase C- and cyclooxygenase-dependent signaling pathways. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[42] A. Struthers,et al. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. , 2000, Circulation.
[43] S. Izumo,et al. Apoptosis: basic mechanisms and implications for cardiovascular disease. , 1998, Circulation research.
[44] U. Ikeda,et al. Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 beta. , 1995, European journal of pharmacology.
[45] W. Waldhäusl,et al. Effect of endothelin-1 in man: impact on basal and adrenocorticotropin-stimulated concentrations of aldosterone. , 1995, The Journal of clinical endocrinology and metabolism.
[46] F. Veglio,et al. Plasma immunoreactive endothelin-1 in primary hyperaldosteronism. , 1994, American journal of hypertension.
[47] A. Lerman,et al. Intact and altered endothelium in regulation of vasomotion. , 1992, Circulation.
[48] W. Campbell,et al. Endothelin enhances adrenocorticotropin-stimulated aldosterone release from cultured bovine adrenal cells. , 1990, Endocrinology.
[49] Fiorenzo Gaita,et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. , 2018, The lancet. Diabetes & endocrinology.
[50] Michael H. Olsen,et al. ESH / ESC Guidelines for the management of arterial hypertension , 2013 .
[51] D. Armanini,et al. Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity. , 2010, Journal of endocrinological investigation.